Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.

Pinder, S E; Campbell, A F; Bartlett, J M S; Marshall, A; Allen, D; Falzon, M; Dunn, J A; Makris, A; Hughes-Davies, L; Stein, R C.

Br J Cancer ; 116(7): 859-863, 2017 Mar 28.

Artigo em Inglês | MEDLINE | ID: mdl-28222072

2.

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.

Earl, H M; Hiller, L; Dunn, J A; Blenkinsop, C; Grybowicz, L; Vallier, A-L; Gounaris, I; Abraham, J E; Hughes-Davies, L; McAdam, K; Chan, S; Ahmad, R; Hickish, T; Rea, D; Caldas, C; Bartlett, J M S; Cameron, D A; Provenzano, E; Thomas, J; Hayward, R L.

Ann Oncol ; 28(8): 1817-1824, 2017 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-28459938

3.

DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Fuks, F; Burgers, W A; Brehm, A; Hughes-Davies, L; Kouzarides, T.

Nat Genet ; 24(1): 88-91, 2000 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-10615135

4.

Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.

Conefrey, C; Donovan, J L; Stein, R C; Paramasivan, S; Marshall, A; Bartlett, J; Cameron, D; Campbell, A; Dunn, J; Earl, H; Hall, P; Harmer, V; Hughes-Davies, L; Macpherson, I; Makris, A; Morgan, A; Pinder, S; Poole, C; Rea, D; Rooshenas, L.

Clin Oncol (R Coll Radiol) ; 32(6): 382-389, 2020 06.

Artigo em Inglês | MEDLINE | ID: mdl-32089356

5.

Tamoxifen: the drug that came in from the cold.

Hughes-Davies, L; Caldas, C; Wishart, G C.

Br J Cancer ; 101(6): 875-8, 2009 Sep 15.

Artigo em Inglês | MEDLINE | ID: mdl-19672259

6.

Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.

Lücke, C D; Philpott, A; Metcalfe, J C; Thompson, A M; Hughes-Davies, L; Kemp, P R; Hesketh, R.

Cancer Res ; 61(2): 482-5, 2001 Jan 15.

Artigo em Inglês | MEDLINE | ID: mdl-11212236

7.

Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No.

Macbeth, F; Hughes-Davies, L.

Clin Oncol (R Coll Radiol) ; 33(12): 749-750, 2021 12.

Artigo em Inglês | MEDLINE | ID: mdl-34218999

8.

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

Earl, H M; Hiller, L; Dunn, J; Macpherson, I; Rea, D; Hughes-Davies, L; McAdam, K; Hall, P; Mansi, J; Wheatley, D; Abraham, J E; Caldas, C; Gasson, S; O'Riordan, E; Wilcox, M; Miles, D; Cameron, D A; Wardley, A.

Clin Oncol (R Coll Radiol) ; 33(1): 15-19, 2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-32723485

9.

The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase.

Milner, J; Fuks, F; Hughes-Davies, L; Kouzarides, T.

Oncogene ; 19(38): 4441-5, 2000 Sep 07.

Artigo em Inglês | MEDLINE | ID: mdl-10980621

10.

Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.

Price, B D; Hughes-Davies, L; Park, S J.

Oncogene ; 11(1): 73-80, 1995 Jul 06.

Artigo em Inglês | MEDLINE | ID: mdl-7624134

11.

Serum cardiac troponin T levels during treatment of early-stage breast cancer.

Hughes-Davies, L; Sacks, D; Rescigno, J; Howard, S; Harris, J.

J Clin Oncol ; 13(10): 2582-4, 1995 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-7595710

12.

Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.

Howard, S P; Park, S J; Hughes-Davies, L; Coleman, C N; Price, B D.

Clin Cancer Res ; 2(2): 269-76, 1996 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-9816169

13.

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.

Hughes-Davies, L; Tarbell, N J; Coleman, C N; Silver, B; Shulman, L N; Linggood, R; Canellos, G P; Mauch, P M.

Int J Radiat Oncol Biol Phys ; 39(2): 361-9, 1997 Sep 01.

Artigo em Inglês | MEDLINE | ID: mdl-9308940

14.

Occult alveolar haemorrhage in bronchopulmonary Kaposi's sarcoma.

Hughes-Davies, L; Kocjan, G; Spittle, M F; Miller, R F.

J Clin Pathol ; 45(6): 536-7, 1992 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-1624606

15.

Technical modifications required to treat cervical chemodactomas with stereotactic radiosurgery.

Hughes-Davies, L; Mannarino, E; Alexander, E; Kooy, H; Loeffler, J S.

Surg Neurol ; 41(5): 418-20, 1994 May.

Artigo em Inglês | MEDLINE | ID: mdl-8009419

16.

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.

Bartlett, J; Canney, P; Campbell, A; Cameron, D; Donovan, J; Dunn, J; Earl, H; Francis, A; Hall, P; Harmer, V; Higgins, H; Hillier, L; Hulme, C; Hughes-Davies, L; Makris, A; Morgan, A; McCabe, C; Pinder, S; Poole, C; Rea, D; Stallard, N; Stein, R.

Clin Oncol (R Coll Radiol) ; 25(2): 109-16, 2013 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-23267818

17.

Quality of life in non-small-cell lung cancer.

Hughes-Davies, L; Billingham, L; Cullen, M.

J Clin Oncol ; 18(8): 1802, 2000 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-10764443

18.

Fournier's gangrene: a hazard of chemotherapy in AIDS.

Hughes-Davies, L T; Murray, P; Spittle, M.

Clin Oncol (R Coll Radiol) ; 3(4): 241, 1991 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-1931768

19.

Cancer and HIV infection.

Hughes-Davies, L; Spittle, M.

BMJ ; 302(6778): 673-4, 1991 Mar 23.

Artigo em Inglês | MEDLINE | ID: mdl-2021739

20.

Cancer and HIV infection.

Hughes-Davies, L; Spittle, M.

BMJ ; 302(6789): 1399, 1991 Jun 08.

Artigo em Inglês | MEDLINE | ID: mdl-1898461

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.

DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.

Tamoxifen: the drug that came in from the cold.

Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.

Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No.

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase.

Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.

Serum cardiac troponin T levels during treatment of early-stage breast cancer.

Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.

Occult alveolar haemorrhage in bronchopulmonary Kaposi's sarcoma.

Technical modifications required to treat cervical chemodactomas with stereotactic radiosurgery.

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.

Quality of life in non-small-cell lung cancer.

Fournier's gangrene: a hazard of chemotherapy in AIDS.

Cancer and HIV infection.

Cancer and HIV infection.